Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
06/2003
06/11/2003EP0968203B1 Photoactive coumarin sulfonate compounds
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
05/2003
05/29/2003US20030100583 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/21/2003EP1268464A4 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof
05/21/2003EP0907646B1 Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
05/21/2003CN1109031C Bicycle-aromatic compound
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092695 Hormone inhibitors; therapy for sexual disorders
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1108300C Thiochrome ketones as antifungal agent
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003CA2462206A1 Substituted thioacetamides
05/07/2003EP1308781A2 Cyclic sulfonium and sulfoxonium photoacid generators and photoresists containing them
05/07/2003EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha)
05/06/2003CA2244194C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/01/2003US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives
04/2003
04/29/2003US6555571 3-methyl -chromane or thiochromane derivatives
04/29/2003US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
04/24/2003WO2003033492A1 Multi-functional thioxanthone photoinitiators
04/24/2003US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases
04/24/2003US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP0993442B1 Hydrazine derivatives
04/23/2003CN1106394C Dihydrobenzopyran and dihydrobenzopyran compound and their use
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
04/22/2003US6552069 3-methyl-chroman and -thiochroman derivatives
04/22/2003US6552068 Having anti-estrogenic activity; for use in therapy
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/15/2003US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity
04/10/2003US20030069224 Non-nucleoside reverse transcriptase inhibitors
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/03/2003US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/03/2003US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate
04/03/2003US20030061671 Thioxanthone dyes with improved solubility and a method of preparing 2-oxybenzanthrones as intermediate materials for making of these dyes
04/02/2003EP0917458B1 Lyophilized thioxanthenone antimumor agents
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
03/2003
03/27/2003WO2002089781A3 Methods of treating hyperlipidemia
03/27/2003US20030060491 Bicyclic aromatic compounds
03/26/2003EP1149089B1 PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
03/26/2003EP1114043B1 Naphthopyrans annelated in c 6?-c 7?, their preparation and compositions and (co)polymer matrices containing them
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6537527 Skin lightening compositions
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP0799228B1 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as anti-parasitic agents
03/18/2003CA2238377C Cyclohexenone oxime ether metal salts
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/12/2003WO2002022596A1 Method for producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
03/12/2003WO2002022568A1 ss-THIO-AMINO ACIDS
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003CA2421995A1 Method for producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
03/11/2003US6531599 Compounds having activity as inhibitors of cytochrome P450RAI
03/05/2003EP1140893B1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/04/2003US6528232 Chemically amplified photoresist composition using the novel sulfonium salt compound as the photoacid generator
02/2003
02/27/2003WO2003016407A1 Thioxanthone dyes with improved solubility and a method of preparing 2-oxybenzanthrones as intermediate materials for making of these dyes
02/27/2003WO2003015790A1 Thiopyrane-4-ones as dna protein kinase inhibitors
02/27/2003WO2002080841A3 Antibacterial oxazolidinones with a cyclic sulphilimine or sulphoximine
02/26/2003EP1286409A1 Nonaqueous electrolytic solution and secondary battery containing the same
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/20/2003WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
02/20/2003WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
02/19/2003EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof
02/18/2003US6521650 Amines as pharmaceutical agents
02/18/2003US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
02/13/2003WO2003011456A1 Thiopyryl cation and derivatives of same trapped in a zeolitic material
02/11/2003US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
02/11/2003CA2047237C Chroman derivatives
02/06/2003WO2003010130A1 Amino acid derivatives
02/06/2003WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
02/05/2003EP1280757A2 New gamma selective retinoids
02/05/2003CN1394858A Cycermanone quaternary antifungal compound
02/04/2003US6515028 Glucamine compounds for treating hepatitis virus infections
02/04/2003US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation
02/04/2003US6514633 Light emitting device material, light emitting device using thereof, and amine compound
01/2003
01/30/2003WO2003008404A2 Sulfonium salts as phtoinitiators for radiation curable systems
01/30/2003US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
01/29/2003EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/29/2003EP0832081B1 Bicyclic-aromatic compounds
01/23/2003WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/23/2003CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 48